BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 33676010)

  • 1. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.
    Verma S; Abbas M; Verma S; Khan FH; Raza ST; Siddiqi Z; Ahmad I; Mahdi F
    Infect Genet Evol; 2021 Jul; 91():104801. PubMed ID: 33676010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?
    Yamamoto N; Yamamoto R; Ariumi Y; Mizokami M; Shimotohno K; Yoshikura H
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of the
    Cenanovic M; Dogan S; Asic A; Besic L; Marjanovic D
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):55-58. PubMed ID: 33470888
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.
    Gómez J; Albaiceta GM; García-Clemente M; López-Larrea C; Amado-Rodríguez L; Lopez-Alonso I; Hermida T; Enriquez AI; Herrero P; Melón S; Alvarez-Argüelles ME; Boga JA; Rojo-Alba S; Cuesta-Llavona E; Alvarez V; Lorca R; Coto E
    Gene; 2020 Dec; 762():145102. PubMed ID: 32882331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.
    Yamamoto N; Ariumi Y; Nishida N; Yamamoto R; Bauer G; Gojobori T; Shimotohno K; Mizokami M
    Gene; 2020 Oct; 758():144944. PubMed ID: 32628976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
    Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
    J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease.
    Alimoradi N; Sharqi M; Firouzabadi D; Sadeghi MM; Moezzi MI; Firouzabadi N
    Virol J; 2022 Mar; 19(1):48. PubMed ID: 35305693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease.
    Najafi M; Mahdavi MR
    Mol Genet Genomics; 2023 Jan; 298(1):27-36. PubMed ID: 36255490
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Yamamoto N; Nishida N; Yamamoto R; Gojobori T; Shimotohno K; Mizokami M; Ariumi Y
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019.
    Zheng H; Cao JJ
    Am J Pathol; 2020 Oct; 190(10):2013-2017. PubMed ID: 32735889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants.
    Sheikhian F; Sadeghi Mofrad S; Tarashi S; Ghazanfari Jajin M; Sakhaee F; Ahmadi I; Anvari E; Sheikhpour M; Fateh A
    Hum Genomics; 2023 Jun; 17(1):54. PubMed ID: 37328914
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Martínez-Gómez LE; Herrera-López B; Martinez-Armenta C; Ortega-Peña S; Camacho-Rea MDC; Suarez-Ahedo C; Vázquez-Cárdenas P; Vargas-Alarcón G; Rojas-Velasco G; Fragoso JM; Vidal-Vázquez P; Ramírez-Hinojosa JP; Rodríguez-Sánchez Y; Barrón-Díaz D; Moreno ML; Martínez-Ruiz FJ; Zayago-Angeles DM; Mata-Miranda MM; Vázquez-Zapién GJ; Martínez-Cuazitl A; Barajas-Galicia E; Bustamante-Silva L; Zazueta-Arroyo D; Rodríguez-Pérez JM; Hernández-González O; Coronado-Zarco R; Lucas-Tenorio V; Franco-Cendejas R; López-Jácome LE; Vázquez-Juárez RC; Magaña JJ; Cruz-Ramos M; Granados J; Hernández-Doño S; Delgado-Saldivar D; Ramos-Tavera L; Coronado-Zarco I; Guajardo-Salinas G; Muñoz-Valle JF; Pineda C; Martínez-Nava GA; López-Reyes A
    Front Immunol; 2022; 13():812940. PubMed ID: 35250987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis.
    Saengsiwaritt W; Jittikoon J; Chaikledkaew U; Udomsinprasert W
    Rev Med Virol; 2022 Jul; 32(4):e2323. PubMed ID: 34997794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are angiotensin converting enzyme (ACE1/ACE2) gene variants associated with the clinical severity of COVID-19 pneumonia? A single-center cohort study.
    Baştuğ S; Çavdarlı B; Baştuğ A; Şencan İ; Tunçez E; Yakışık Çakır E; Kemirtlek N; Sakar C; Erdem D; Güleç Ceylan G; Özkoçak Turan I; Kazancıoğlu S; Bodur H
    Anatol J Cardiol; 2022 Feb; 26(2):133-140. PubMed ID: 35190362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality.
    Mir MM; Mir R; Alghamdi MAA; Alsayed BA; Wani JI; Alharthi MH; Al-Shahrani AM
    J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single Nucleotide Variants (SNVs) of Angiotensin-Converting Enzymes (ACE1 and ACE2): A Plausible Explanation for the Global Variation in COVID-19 Prevalence.
    Atiku SM; Kasozi D; Campbell K
    J Renin Angiotensin Aldosterone Syst; 2023; 2023():9668008. PubMed ID: 37051471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNFα genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
    Pecoraro V; Cuccorese M; Trenti T
    Clin Exp Med; 2023 Nov; 23(7):3251-3264. PubMed ID: 37055652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.
    Sabater Molina M; Nicolás Rocamora E; Bendicho AI; Vázquez EG; Zorio E; Rodriguez FD; Gil Ortuño C; Rodríguez AI; Sánchez-López AJ; Jara Rubio R; Moreno-Docón A; Marcos PJ; García Pavía P; Villa RB; Gimeno Blanes JR
    PLoS One; 2022; 17(2):e0263140. PubMed ID: 35120165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin-angiotensin-aldosterone system on COVID-19 disease.
    Zobel CM; Kuhn H; Schreiner M; Wenzel W; Wendtland J; Goekeri C; Scheit L; Oltmanns K; Rauschning D; Grossegesse M; Hofmann N; Wirtz H; Spethmann S;
    Virol J; 2024 Jan; 21(1):15. PubMed ID: 38200555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.